These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7908399)

  • 1. Long-term 'treatment' of schizophrenics with typical neuroleptics: a crime against humanity?
    Elomaa E
    Med Hypotheses; 1993 Nov; 41(5):434. PubMed ID: 7908399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics.
    Juckel G; Schlagenhauf F; Koslowski M; Filonov D; Wüstenberg T; Villringer A; Knutson B; Kienast T; Gallinat J; Wrase J; Heinz A
    Psychopharmacology (Berl); 2006 Aug; 187(2):222-8. PubMed ID: 16721614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the reward system by antipsychotic treatment.
    Juckel G
    Dialogues Clin Neurosci; 2016 Mar; 18(1):109-14. PubMed ID: 27069385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Depot neuroleptics in social psychiatric practice].
    Pruss U; Rose HK; Zechner A
    Psychiatr Prax; 1984 Jul; 11(4):101-8. PubMed ID: 6148764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of neuroleptics on specific syndromes and symptoms in schizophrenics with unfavourable long-term course. A 5-year follow-up study of 50 chronic schizophrenics.
    Beckmann H; Fritze J; Franzek E
    Neuropsychobiology; 1992; 26(1-2):50-8. PubMed ID: 1361971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Viewpoint of schizophrenic patients: a European survey].
    Courtet P
    Encephale; 2001; 27(1):28-38. PubMed ID: 11294036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
    Wiesel FA
    Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do neuroleptics cause depression?
    Roy A
    Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depot neuroleptic therapy: clinical considerations.
    Remington GJ; Adams ME
    Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of late-life schizophrenia with neuroleptics.
    Jeste DV; Lacro JP; Gilbert PL; Kline J; Kline N
    Schizophr Bull; 1993; 19(4):817-30. PubMed ID: 7905663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amoral--or only hopelessly backward? Arguments against the condemnation of conventional neuroleptics. Invitation to discussion].
    Finzen A
    Psychiatr Prax; 2000 Nov; 27(8):365-6. PubMed ID: 11140157
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients.
    Cassens G; Inglis AK; Appelbaum PS; Gutheil TG
    Schizophr Bull; 1990; 16(3):477-99. PubMed ID: 1981108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepines in the treatment of schizophrenia: an updated survey.
    Lingjaerde O
    Acta Psychiatr Scand; 1991 Nov; 84(5):453-9. PubMed ID: 1685616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic-resistant schizophrenics.
    Murray JB
    J Psychol; 1989 Jan; 123(1):69-78. PubMed ID: 2564435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent developments in antipsychotic medication].
    Möller HJ
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(5):230-9. PubMed ID: 8658104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet MAO in schizophrenics: relationship to symptomatology and neuroleptics.
    Paik IH; Lee C; Kim CE
    Biol Psychiatry; 1988 Jan; 23(1):93-5. PubMed ID: 2892539
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study.
    Galdi J; Rieder RO; Silber D; Bonato RR
    Psychol Med; 1981 Nov; 11(4):713-28. PubMed ID: 6119718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Schizophrenia, diabetes and new neuroleptics].
    Ambresin G; Bryois Ch
    Praxis (Bern 1994); 2002 Dec; 91(50):2181-92. PubMed ID: 12520727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic strategies for augmenting cognitive performance in schizophrenia.
    Friedman JI; Temporini H; Davis KL
    Biol Psychiatry; 1999 Jan; 45(1):1-16. PubMed ID: 9894570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.